跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
SAATIN 40
Approved
STANDARD
SAATIN 40
Hizon Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
83d94d721a8f520c
Company
Hizon Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
83d94d721a8f520c
Drug Approval Philippines Name
SAATIN 40
Product Name
SAATIN 40
Registration Number
DRP-6540-01
Brand Name
SAATIN 40
Generic Name
ATORVASTATIN (AS CALCIUM)
Dosage Form
Film-Coated Tablet
Dosage Strength
40 mg
Manufacturer
Hizon Laboratories, Inc.
Distributor
GX International, Inc.
Issuance Date
28 March 2024
Expiry Date
08 July 2029
Pharmacologic Category
HMG CoA REDUCTASE INHIBITORS
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
83d94d721a8f520c
Type
Standard
Back to Philippines FDA Approvals
SAATIN 40 - Philippines FDA Drug Approval Details